Efficacy of a fixed-dose combination (amlodipine/losartan) in the treatment of a patient with arterial hypertension, dyslipidemia and obesity-Reference-Cited by-同舟云学术

Efficacy of a fixed-dose combination (amlodipine/losartan) in the treatment of a patient with arterial hypertension, dyslipidemia and obesity

Published:2020-01-28 Issue:21 Volume: Page:74-78
ISSN:2658-5790
Container-title:Medical Council
language:
Short-container-title:Medicinskij sovet

Author:

Mikhin V. P.¹^ORCID

Affiliation:

1. Kursk State Medical University

Abstract

The article substantiates the feasibility of combination antihypertensive therapy in patients with arterial hypertension without target organ damage and high cardiovascular risk. The authors consider a clinical case of the use of amlodipine and losartan in a fixed-dose combination (Lozap AM) as part of complex therapy in a patient with arterial hypertension, dyslipidemia and obesity. The clinical case showed the ability of the drug to both achieve a steady level of target blood pressure and improve its daily profile by transferring the Night-peaker type to the Non-dipper type.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference18 articles.

1. Boytsov S.A., Luk’yanov M.M., Yakushin S.S., Martsevich S.Yu., Vorobyov A.N., Zagrebelny A.V., Pereverzeva K.G., Pravkina E.A., Deev A.D., Andreenko E.Yu., Ershova A.I., Meshkov A.N., Myasnikov R.P., Serdyuk S.S., Kharlap M.S., Bazaeva E.V., Kozminsky A.N., Moseychuk K.A., Kudryashov E.N. Cardiovascular diseases registry (RECVAZA): diagnostics, concomitant cardiovascular pathology, comorbidities and treatment in the real outpatient-polyclinic practice. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2014;13(6):44-59. (In Russ.) doi: 10.15829/1728-8800-2014-6-44-50.

2. Erina A.M., Rotar O.P., Solntsev V.N., Shalnova S.A., Deev A.D., Baranova E.I., Konradi O.A., Boytsov S.A., Shlyakhto E.V. Epidemiology of Arterial Hypertension in Russian Federation – Importance of Choice of Criteria of Diagnosis. Kardiologiya = Kardiologiia. 2019;59(6):5-11. (In Russ.) doi: 10.18087/cardio.2019.6.2595

3. Cardiovascular prevention 2017. National guidelines. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2018;(6):7-122. (In Russ.) doi: 10.15829/1560-4071-2018-6-7-122

4. Boytsov S.A., Shalnova S.A., Deev A.D. Cardiovascular mortality in the Russian Federation and possible mechanisms of its changes. Zhurnal nevrologii i psikhiatrii im. C.C. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(8):98-103. (In Russ). Available at: https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-skorsakova/2018/8/downloads/ru/1199772982018081098.

5. Puzin S.N., Dymochka M.A., Boitsov S.A., Shurgaya M.A., Govorushkina N.S., Krivoruchko Yu.D., Chandirli S.A., Malichenko V.S. The epidemiological picture of the disability in various demographic contingents of the population in the russian federation in the aspect of the social policy of the state. Mediko-sotsial’naya ehkspertiza i reabilitatsiya = Medical and social expert evaluation and rehabilitation. 2018;(1-2):50-54. (In Russ.) Available at: http://www.medlit.ru/journalsview/reha/view/journal/2018/issue-1/389-epidemiologicheskaya-kartina-invalidnosti-u-razlichnyh-demograficheskih-kontingentov-naseleniya-v-rossiyskoy-federacii-v-aspektesocial-noy-politiki-gosudarstva/